EP1845961
Meðhöndlun á segarekstruflunum með rívaroxabani
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
19.1.2006EP published:
22.4.2015EP application number:
06706291.9
EP translation filed:
13.7.2015Grant published:
15.8.2015EPO information:
European Patent Register
Max expiry date:
18.1.2026Expiry date:
18.1.2026
Title:
TREATMENT OF THROMBOEMBOLIC DISORDERS WITH RIVAROXABAN
Timeline
Today
19.1.2006EP application
22.4.2015EP Publication
13.7.2015Translation submitted
15.8.2015Registration published
18.1.2026Expires
Owner
Name:
Bayer Intellectual Property GmbHAddress:
Alfred-Nobel-Strasse 50, 40789, Monheim am Rhein, DE
Inventor
Name:
MISSELWITZ, FrankAddress:
Heidelberg, DE
Name:
KUBITZA, DagmarAddress:
Ratingen, DE
Name:
PARK, Son-MiAddress:
Wuppertal, DE
Name:
WEHLING, KlausAddress:
Wuppertal, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
05001893Date:
31.1.2005Country:
EP
Classification
Categories:
A61K 31/00, A61K 31/5377, A61P 7/02, A61P 9/10
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 28.12.2015
Expires: 18.1.2017
Payer: Árnason Faktor
Number: 12
Paid: 28.12.2016
Expires: 18.1.2018
Payer: Árnason Faktor
Number: 13
Paid: 29.12.2017
Expires: 18.1.2019
Payer: Árnason Faktor
Number: 14
Paid: 2.1.2019
Expires: 18.1.2020
Payer: Árnason Faktor
Number: 15
Paid: 31.12.2019
Expires: 18.1.2021
Payer: Árnason Faktor ehf.
Number: 16
Paid: 29.12.2020
Expires: 18.1.2022
Payer: Árnason Faktor ehf.
Number: 17
Paid: 28.12.2021
Expires: 18.1.2023
Payer: Árnason Faktor ehf.
Number: 18
Paid: 28.12.2022
Expires: 18.1.2024
Payer: Árnason Faktor ehf.
Number: 19
Paid: 27.12.2023
Expires: 18.1.2025
Payer: Árnason Faktor ehf.
Number: 20
Paid: 27.12.2024
Expires: 18.1.2026
Payer: Árnason Faktor ehf.